IP Library Granted Patent US 10,408,735
Granted Patent B2
US 10,408,735 · App. 15/024,413 · Granted Sep 10, 2019

In vitro method for the label-free determination of a cell type of a cell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,408,735
App. No.
15/024,413
Filed
Mar 24, 2016
Granted
Sep 10, 2019
Kind
B2
Art Unit
1651
USPC
435/34
Abstract

An in vitro method for the marker-free determination of a cell type of a cell in a biological sample is disclosed, a microscopic device being configured to detect a height profile of the cell with respect to a carrier plate. An embodiment of the method performed by a cell analysis device, include: determining a cell compartment of the cell on the basis of the detected height profile, determining a predetermined quantitative cell feature on the basis of the determined cell compartment, and determining the cell type of the cell on the basis of the determined quantitative cell feature. A correspondingly designed cell analysis device and a corresponding microscopic device are also disclosed.

Claims (17)

1. An in vitro, marker-free method for distinguishing a leukocyte in a biological sample comprising cells, the method comprising:

detecting a height profile of a cell in the biological sample with respect to a carrier plate with a microscopy device;

identifying a cell compartment of the cell using the detected height profile;

determining a quantitative cell feature using the identified cell compartment; and

distinguishing the cell by comparing the quantitative cell feature of the cell to an equivalent quantitative cell feature of a known leukocyte; and determining whether the quantitative cell feature of the cell is similar to the equivalent quantitative cell feature of the known leukocyte, thereby distinguishing the type of leukocyte of the cell.

2. The method of claim 1 , wherein the quantitative cell feature corresponds to at least one of a cell volume, a volume of the cell compartment, a cell area, an area of the cell compartment, a ratio of a cell volume to a cell nucleus volume, a ratio of a cell area to a cell nucleus area, a diameter, a roundness or a circumference of the cell compartment, a number of cell compartments of the cell and a statistical feature of a cell feature which is determined using the respective height profile of a plurality of cells.

3. The method of claim 1 , comprising distinguishing the cell by comparing two quantitative cell features of the cell to two equivalent quantitative cell features of the known leukocyte.

4. The method of claim 1 , wherein the height profile is determined by at least one of superimposing a reference wave on an object wave, recording a resulting interferogram and a mathematical reconstruction.

5. The method of claim 1 , wherein the height profile is detected via digital holographic microscopy, interference phase microscopy or quantitative phase microscopy.

6. The method of claim 1 , wherein the method is carried out with at least one of an undyed and undried cell.

7. The method of claim 1 , wherein the method is carried out using a whole blood sample.

8. The method of claim 1 , wherein a cell functionality is determined.

9. The method of claim 1 , wherein a cell stage of the cell is determined.

10. The method claim 8 , wherein the determining of the cell functionality includes determining an activation state of a cell and the detection of the height profile of the cell includes detecting a pathogen-affected cell.

11. The method of claim 9 , wherein the determining of a cell stage of the cell includes differentiating a cell age.

12. The method of claim 1 , wherein a physiological or morphological state of the cell is determined.

13. The method of claim 1 , wherein an activity state of the cell is determined.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 066088 FRAME: 0256. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 17, 2024
From: SIEMENS HEALTHCARE GMBH
To: SIEMENS HEALTHINEERS AG
Reel/Frame 071178/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2023
From: SIEMENS HEALTHCARE GMBH
To: SIEMENS HEALTHINEERS AG
Reel/Frame 066088/0256 →